While we were preparing this manuscript, a study reported a small molecule targeting myoferlin with significant antitumour effect on breast cancer and on several other cancer cell types, including pancreas cancer, prostate cancer, and ovarian cancer53. Here, MYOF is linked to prostate carcinoma.